FDG-PET/CT for the evaluation of response to therapy of cutaneous T-cell lymphoma to vorinostat (suberoylanilide hydroxamic acid, SAHA) in a phase II trial (Q40065280)
Jump to navigation
Jump to search
scientific article published on 30 July 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | FDG-PET/CT for the evaluation of response to therapy of cutaneous T-cell lymphoma to vorinostat (suberoylanilide hydroxamic acid, SAHA) in a phase II trial |
scientific article published on 30 July 2008 |
Statements
1 reference
FDG-PET/CT for the evaluation of response to therapy of cutaneous T-cell lymphoma to vorinostat (suberoylanilide hydroxamic acid, SAHA) in a phase II trial (English)
1 reference
Phillip H Kuo
1 reference
Kacie R Carlson
1 reference
Inger Christensen
1 reference
Michael Girardi
1 reference
Peter W Heald
1 reference
30 July 2008
1 reference
1 reference
10
1 reference
6
1 reference
306-314
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference